Literature DB >> 15461234

Dietary supplements in primary care. Botanicals can affect surgical outcomes and follow-up.

Jerry O Ciocon1, Daisy G Ciocon, Diana J Galindo.   

Abstract

Dietary supplements are commonly used by patients of all ages, yet few patients reveal use of these products to their medical providers. Certain dietary supplements can react or interact with frequently used surgical medications--including anesthesia--and may cause serious unforeseen consequences or complications. Arrhythmias, poor wound healing, bleeding, photosensitivity reaction, and prolonged sedation are among the serious reactions during and after surgical and diagnostic procedures that have been attributed to these products. This article reviews the effects of the Few Gs (feverfew, ginkgo biloba, garlic, ginseng, and ginger), valerian, kava, St. John's wort, ephedra (Ma huang or metabolite), and echinacea. We recommend that all patients be advised to stop all dietary supplements at least 1 week prior to major surgical or diagnostic procedures; if a complication is noted, continued use of these products should be reviewed with patients.

Entities:  

Mesh:

Year:  2004        PMID: 15461234

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  3 in total

1.  Cardamom ingestion as a possible cause of hematuria.

Authors:  Pietro Ferrara; Iliana Bersani; Giorgia Bottaro; Ottavio Vitelli; Antonio Gatto; Francesca del Bufalo; Pio Liberatore; Lorenza Romani; Achille Stabile
Journal:  Indian J Pediatr       Date:  2011-06-10       Impact factor: 1.967

2.  Dietary supplement adverse events: report of a one-year poison center surveillance project.

Authors:  Christine Haller; Tom Kearney; Stephen Bent; Richard Ko; Neal Benowitz; Kent Olson
Journal:  J Med Toxicol       Date:  2008-06

3.  Zingiber officinale Improves Cognitive Function of the Middle-Aged Healthy Women.

Authors:  Naritsara Saenghong; Jintanaporn Wattanathorn; Supaporn Muchimapura; Terdthai Tongun; Nawanant Piyavhatkul; Chuleratana Banchonglikitkul; Tanwarat Kajsongkram
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-22       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.